Prostate cancer risk and consumption of fish oils: A dietary biomarker-based case–control study

Abstract

Experimental studies suggest that the risk of prostate cancer is reduced with the intake of long-chain n-3 polyunsaturated fatty acids derived from marine foods, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). However, few human studies have been conducted due to difficulties in assessing the dietary intake of these fatty acids. The authors examined the relationship between prostate cancer risk and EPA and DHA in erythrocyte biomarkers in a population-based case-control study in Auckland, New Zealand during 1996-1997 involving 317 prostate cancer cases and 480 age-matched community controls. Reduced prostate cancer risk was associated with high erythrocyte phosphatidylcholine levels of EPA (multivariate relative risk = 0.59; 95% confidence interval 0.37-0.95, upper vs lowest quartile) and DHA (multivariate relative risk = 0.62; 95% confidence interval 0.39-0.98, upper vs lowest quartile). These analyses support evidence from in vitro experiments for a reduced risk of prostate cancer associated with dietary fish oils, possibly acting via inhibition of arachidonic acid-derived eicosanoid biosynthesis.

References 25

1. 1.

   Agren J. J., Hänninen O. O. Effect of moderate freshwater fish diet on erythrocyte ghost phospholipid fatty acids. Ann Med. 1991;23(3):261-263.

   Not in our library10.3109/07853899109148057

2. 2.

   BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911-917.

   Not in our library10.1139/o59-099

3. 3.

   Baró L., Hermoso J. C., Núez M. C., Jiménez-Rios J. A., Gil A. Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer. Br J Cancer. 1998;77(11):1978-1983.

   Not in our library10.1038/bjc.1998.328

4. 4.

   Brown A. J., Pang E., Roberts D. C. Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. Am J Clin Nutr. 1991;54(4):668-673.

   Not in our library10.1093/ajcn/54.4.668

5. 5.

   Chaudry A. A., Wahle K. W., McClinton S., Moffat L. E. Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors. Int J Cancer. 1994;57(2):176-180.

   Not in our library10.1002/ijc.2910570208

6. 6.

   Earnest D. L., Hixson L. J., Alberts D. S. Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J Cell Biochem Suppl. 1992;16I:156-166.

   Not in our library10.1002/jcb.240501330

7. 7.

   Ewings P., Bowie C. A case-control study of cancer of the prostate in Somerset and east Devon. Br J Cancer. 1996;74(4):661-666.

   Not in our library10.1038/bjc.1996.418

8. 8.

   Gann P. H., Hennekens C. H., Sacks F. M., Grodstein F., Giovannucci E. L., Stampfer M. J. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst. 1994;86(4):281-286.

   Not in our library10.1093/jnci/86.4.281

9. 9.

   Giovannucci E., Rimm E. B., Colditz G. A., Stampfer M. J., Ascherio A., Chute C. G., Chute C. C., Willett W. C. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst. 1993;85(19):1571-1579.

   Not in our library10.1093/jnci/85.19.1571

10. 10.

    Glatz J. F., Soffers A. E., Katan M. B. Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr. 1989;49(2):269-276.

    Not in our library10.1093/ajcn/49.2.269

11. 11.

    Godley P. A., Campbell M. K., Gallagher P., Martinson F. E., Mohler J. L., Sandler R. S. Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiol Biomarkers Prev. 1996;5(11):889-895.

    Not in our library

12. 12.

    Godley P. A., Campbell M. K., Miller C., Gallagher P., Martinson F. E., Mohler J. L., Sandler R. S. Correlation between biomarkers of omega-3 fatty acid consumption and questionnaire data in African American and Caucasian United States males with and without prostatic carcinoma. Cancer Epidemiol Biomarkers Prev. 1996;5(2):115-119.

    Not in our library

13. 13.

    Harvei S., Bjerve K. S., Tretli S., Jellum E., Robsahm T. E., Vatten L. Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer. 1997;71(4):545-551.

    Not in our library10.1002/(sici)1097-0215(19970516)71:4<545::aid-ijc7>3.0.co;2-u

14. 14.

    Holub B. J., Skeaff C. M. Nutritional regulation of cellular phosphatidylinositol. Methods Enzymol. 1987;141:234-244.

    Not in our library10.1016/0076-6879(87)41071-9

15. 15.

    Kolonel L. N. Nutrition and prostate cancer. Cancer Causes Control. 1996;7(1):83-44.

    Not in our library10.1007/bf00115640

16. 16.

    Lupulescu A. Prostaglandins, their inhibitors and cancer. Prostaglandins Leukot Essent Fatty Acids. 1996;54(2):83-94.

    Not in our library10.1016/s0952-3278(96)90064-2

17. 17.

    Mantzioris E., James M. J., Gibson R. A., Cleland L. G. Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am J Clin Nutr. 1994;59(6):1304-1309.

    Not in our library10.1093/ajcn/59.6.1304

18. 18.

    Mishina T., Watanabe H., Araki H., Nakao M. Epidemiological study of prostatic cancer by matched-pair analysis. Prostate. 1985;6(4):423-436.

    Not in our library10.1002/pros.2990060411

19. 19.

    Nomura A. M., Kolonel L. N. Prostate cancer: a current perspective. Epidemiol Rev. 1991;13:200-227.

    Not in our library10.1093/oxfordjournals.epirev.a036069

20. 20.

    Norrish A. E., Jackson R. T., McRae C. U. Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer. 1998;77(4):511-515.

    Not in our library10.1002/(sici)1097-0215(19980812)77:4<511::aid-ijc6>3.0.co;2-x

21. 21.

    Pandalai P. K., Pilat M. J., Yamazaki K., Naik H., Pienta K. J. The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Res. 1996;16(2):815-820.

    Not in our library

22. 22.

    Rose D. P., Connolly J. M. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate. 1991;18(3):243-254.

    Not in our library10.1002/pros.2990180306

23. 23.

    Rose D. P. Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr. 1997;66(6 Suppl):1513S-1522S.

    Not in our library10.1093/ajcn/66.6.1513s

24. 24.

    Sanders T. A., Roshanai F. The influence of different types of omega 3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers. Clin Sci (Lond). 1983;64(1):91-99.

    Not in our library10.1042/cs0640091

25. 25.

    Vajreswari A., Narayanareddy K. Effect of dietary fats on erythrocyte membrane lipid composition and membrane-bound enzyme activities. Metabolism. 1992;41(4):352-358.

    Not in our library10.1016/0026-0495(92)90067-k

Cited by papers we hold 1

• Are all n-3 polyunsaturated fatty acids created equal? · 2009
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.